Processing

Please wait...

Settings

Settings

Goto Application

1. WO2017197648 - PHARMACEUTICAL COMPOSITION FOR TREATING CARDIOPATHY

Publication Number WO/2017/197648
Publication Date 23.11.2017
International Application No. PCT/CN2016/082851
International Filing Date 20.05.2016
IPC
C12N 5/00 2006.01
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
A61K 31/353 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
A61P 9/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
CPC
A61K 31/353
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
C12N 5/00
CCHEMISTRY; METALLURGY
12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
5Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor;
Applicants
  • 绿恩生化科技股份有限公司 NUMEN BIOTECH CO., LTD [CN]/[CN]
Inventors
  • 刘绍毅 LIOU, Shaw-Yih
  • 黄志扬 HUANG, Chih-Yang
  • 刘才睿 LIOU, Tsai-Jui
  • 陈冬生 CHEN, Tung-Sheng
  • 刘懿德 LIOU, I-Te
Agents
  • 北京元本知识产权代理事务所 BEIJING YUANBEN INTELLECTUAL PROPERTY LAW OFFICE
Priority Data
Publication Language Chinese (ZH)
Filing Language Chinese (ZH)
Designated States
Title
(EN) PHARMACEUTICAL COMPOSITION FOR TREATING CARDIOPATHY
(FR) COMPOSITION PHARMACEUTIQUE DESTINÉE AU TRAITEMENT DE LA CARDIOPATHIE
(ZH) 一种治疗心脏病的医药组合物
Abstract
(EN)
A pharmaceutical composition for treating diabetic cardiopathy. The composition comprises an ester type catechin (EGCG) and adipose-derived stem cells. The ester type catechin (EGCG) could enhance the ability of the adipose-derived stem cells and increase the ability of the adipose-derived stem cells in repairing damaged tissues.
(FR)
La présente invention concerne une composition pharmaceutique destinée au traitement de la cardiopathie diabétique. La composition comprend une catéchine de type ester (EGCG) et des cellules souches dérivées du tissu adipeux. La catéchine de type ester (EGCG) pourrait améliorer la capacité des cellules souches dérivées du tissu adipeux et augmenter la capacité des cellules souches dérivées du tissu adipeux à réparer des tissus adipeux endommagés.
(ZH)
一种修复糖尿病性心脏病的医药组合物,组合物含有酯型儿茶素(EGCG)和脂肪干细胞,酯型儿茶素(EGCG)能提升脂肪干细胞能力,增加脂肪干细胞修复受损组织的能力。
Also published as
Latest bibliographic data on file with the International Bureau